Back
Sarepta Therapeutics Vs. Live Nation Entertainment Industry Stock Comparison
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
129.25
Seasonality Move:
2.77%
Buy
79
LYV
Live Nation Entertainment
Last Price:
101.99
Seasonality Move:
1.72%
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $130.83. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
79
Live Nation Entertainment (LYV)
is a Buy
Is Live Nation Entertainment a Buy, Sell or Hold?
- The current Live Nation Entertainment [LYV] share price is $99.43. The Score for LYV is 79, which is 58% above its historic median score of 50, and infers lower risk than normal.
- LYV is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $130.83
The current trend is moderately bearish and SRPT is experiencing slight buying pressure.
LYV Stock Price Chart
What is Live Nation Entertainment's stock price today?
-
The Live Nation Entertainment share price today is $99.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYV is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.93 | Buy |
| Relative Strength Index (14 RSI): | 54.45 | Buy |
| Chaikin Money Flow: | 174334 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.1 - 134.22) | Buy |
| Bollinger Bands (100): | (113.61 - 133.07) | Buy |
LYV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.42 | Buy |
| Relative Strength Index (14 RSI): | 62.13 | Buy |
| Chaikin Money Flow: | 1704030 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.46 - 96.48) | Buy |
| Bollinger Bands (100): | (89.1 - 100.92) | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 131.99 | Sell |
| 20-day SMA: | 130.38 | Buy |
| 50-day SMA: | 126.51 | Buy |
| 200-day SMA: | 113.64 | Buy |
| 8-day EMA: | 131.77 | Sell |
| 20-day EMA: | 130.2 | Buy |
| 50-day EMA: | 127.07 | Buy |
| 200-day EMA: | 118.36 | Buy |
LYV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 96.79 | Buy |
| 20-day SMA: | 93.6 | Buy |
| 50-day SMA: | 98.32 | Buy |
| 200-day SMA: | 89.96 | Buy |
| 8-day EMA: | 96.69 | Buy |
| 20-day EMA: | 95.57 | Buy |
| 50-day EMA: | 95.84 | Buy |
| 200-day EMA: | 91.38 | Buy |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.09 per share.
Live Nation Entertainment Earnings Growth & LYV Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.80 per share, a decrease next quarter of $0.75 per share, a decrease this year of $0.15 per share, and an increase next year of $0.97 per share.
Sarepta Therapeutics Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Live Nation Entertainment Technical Analysis
| May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||